recombinant human hyaluronidase PH20

DRUG4 trials

Sponsors

Halozyme Therapeutics

Conditions

Diabetes Mellitus, Type 1Diabetes Mellitus, Type IIType 1 Diabetes Mellitus

Phase 2

Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus

CompletedNCT00883558

Halozyme TherapeuticsDiabetes Mellitus, Type 1

Start: 2009-05-31End: 2010-04-30Updated: 2014-09-08

Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus

CompletedNCT01194258

Halozyme TherapeuticsDiabetes Mellitus, Type II

Start: 2010-08-31End: 2011-08-31Updated: 2014-08-20

Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus

CompletedNCT01194245

Halozyme TherapeuticsDiabetes Mellitus, Type 1

Start: 2010-08-31End: 2011-08-31Updated: 2019-02-26

Phase 4

Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase

CompletedNCT01526733

Halozyme TherapeuticsType 1 Diabetes Mellitus

Start: 2011-12-31End: 2013-09-30Updated: 2019-02-26